OR | 95% CI | P | OR | 95% CI | P | |
---|---|---|---|---|---|---|
Male | 1.71 | 0.66–4.43 | 0.27 | |||
Postoperative usage of somatostatin | 0.39 | 0.53–0.97 | 0.04 | 0.39 | 0.15–0.93 | 0.04 |
Age | 0.98 | 0.95–1.01 | 0.12 | |||
BMI | 0.98 | 0.73–1.29 | 0.86 | |||
Anatomy of fistula | ||||||
Stump | Ref. | |||||
Bulb or descending portion | 1.58 | 0.82–3.05 | 0.18 | |||
Pars horizontalis duodeni | 1.38 | 0.36–5.21 | 0.64 | |||
Etiology | ||||||
Upper gastrointestinal tract tumor | Ref. | |||||
Trauma | 1.82 | 0.55–5.99 | 0.33 | |||
Pancreatitis | 4.43 | 1.14–17.09 | 0.03 | 4.14 | 1.05–16.29 | 0.04 |
High output | 0.82 | 0.34–2.00 | 0.67 | |||
Combined with abdominal hernia | 0.89 | 0.44–1.82 | 0.77 | |||
Preoperative hemoglobin | ||||||
≥ 120 g/L | Ref. | |||||
> 100 g/L, and < 120 g/L | 1.13 | 0.46–2.79 | 0.79 | |||
Preoperative albumin | ||||||
≥ 35 g/L | Ref. | |||||
> 30 g/L, and < 35 g/L | 2.04 | 0.81–5.00 | 0.13 | |||
Blood loss | ||||||
< 1000 mL | Ref. | |||||
≥ 1000 mL | 1.09 | 0.45–2.64 | 0.86 | |||
Glutamic pyruvic transaminase | 1.01 | 0.77–1.21 | 0.74 | |||
Total bilirubin | 0.94 | 0.41–1.49 | 0.69 | |||
Creatinine | 0.99 | 0.56–1.28 | 0.61 | |||
Duration of definitive surgery | ||||||
< 4 h | Ref. | |||||
≥ 4 h | 1.31 | 0.54–3.18 | 0.56 | |||
Surgical procedure | ||||||
Suture | Ref. | |||||
Duodenojejunostomy Roux-en-Y | 1.13 | 0.44–2.87 | 0.79 | |||
Required blood transfusion within 48 h after definitive surgery | ||||||
< 1000 mL | Ref. | |||||
≥ 1000 mL | 1.11 | 0.45–2.76 | 0.82 | |||
Required albumin transfusion within 48 h after definitive surgery | ||||||
< 100 g | Ref. | |||||
≥ 100 g | 1.49 | 0.61–3.64 | 0.38 | |||
Hypertension | 2.39 | 0.24–24.04 | 0.46 | |||
Diabetes mellitus | 1.86 | 0.48–7.17 | 0.37 |